US2020385389A1PendingUtilityA1
Small-molecule hsp90 inhibitors
Assignee: SLOAN KETTERING INST CANCER RESPriority: Feb 1, 2005Filed: Apr 24, 2020Published: Dec 10, 2020
Est. expiryFeb 1, 2025(expired)· nominal 20-yr term from priority
Inventors:Gabriela ChiosisHuazhong HeLaura Llauger-BufiJoungnam KimSteven M. LarsonPeter Smith-Jones
C07D 519/00A61P 35/00C07D 473/34
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Purine scaffold Hsp90 inhibitors are useful in therapeutic applications and as radioimaging ligands.
Claims
exact text as granted — not AI-modified1 - 35 . (canceled)
36 . A method of preparing a compound of formula:
or a pharmaceutically acceptable salt thereof;
the method comprising reacting a compound of formula IN-1:
with NHR 1 R 2 in the presence of a base;
wherein:
X 3 is hydrogen or halogen;
X 1 X 1 is a C 1 to C 10 alkyl, alkenyl, or alkynyl group, wherein the alkyl, alkenyl, or alkynyl group includes a nitrogen atom;
the linker is CH2 or S;
X 2 is halogen, alkyl, alkoxy, halogenated alkoxy, hydroxyalkyl, pyrollyl, optionally substituted aryloxy, alkylamino, dialkylamino, carbamyl, amido, alkylamido dialkylamido, acylamino, alkylsulfonylamido, trihalomethoxy, trihalocarbon, thioalkyl, COO-alkyl, NH 2 , OH, CN, SO 2 X 7 , NO 2 , NO, C═SR 2a , NHSO 2 X 7 , or C═OR 2a , where X 7 is F, NH 2 , alkyl or H, and R 2a is alkyl, NH 2 , NH-alkyl or O-alkyl;
R 1 and R 2 are each independently hydrogen or a C 1 to C 10 alkyl, alkenyl, or alkynyl group;
n is 1 or 2;
m is 0, 1, or 2; and
the halo group is Cl, Br, or I.
37 . The method of claim 36 , further comprising the step of preparing the compound of formula IN-1 by reacting a compound of formula IN-2:
with Halo-(CH 2 ) p —OH,
wherein:
p is 1, 2, or 3;
the halo group is Cl, Br, or I.
38 . The method of claim 37 , further comprising the step of preparing the compound of formula IN-2 by reacting a compound of formula IN-3:
with a compound of formula IN-4:
in the presence of a transition metal catalyst and a base;
wherein the halo group is Cl, Br, or I.
39 . The method of claim 38 , further comprising the step of preparing the compound of formula IN-3 by reacting a compound of formula IN-8:
with CS 2 .
40 . The method of claim 37 , further comprising the step of preparing the compound of formula IN-2 by reacting a compound of formula IN-5:
with a compound of formula IN-6:
wherein the halo group is Cl, Br, or I.
41 . The method of claim 37 , wherein the reaction is carried out in the presence of PPh 3 and an azodicarboxylate.
42 . The method claim 37 , wherein X 3 is F in the compound of formula IN-2, and further comprising the step of preparing the compound of formula IN-2 by reacting a compound of formula IN-7:
with a fluorine source.
43 . The method of claim 42 , wherein the step of preparing the compound of formula IN-2 comprises HF-pyridine and a nitrite salt.
44 . The method of claim 42 , wherein the linker is CH 2 in the compound of formula IN-7, and further comprising the step of preparing the compound of formula IN-7 by reacting a compound of formula IN-9:
with a base.
45 . The method of claim 44 , further comprising the step of preparing the compound of formula IN-9 by reacting a compound of formula IN-10:
with a compound of formula IN-11:Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.